Quest Diagnostics (DGX)
(Delayed Data from NYSE)
$153.56 USD
+0.72 (0.47%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $153.57 +0.01 (0.01%) 7:58 PM ET
2-Buy of 5 2
A Value C Growth F Momentum B VGM
Balance Sheet
Fiscal Year End for Quest Diagnostics Incorporated falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 686 | 315 | 872 | 1,158 | 1,192 |
Receivables | 1,210 | 1,195 | 1,438 | 1,520 | 1,063 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 190 | 192 | 208 | 223 | 123 |
Other Current Assets | 286 | 196 | 223 | 157 | 112 |
Total Current Assets | 2,372 | 1,898 | 2,741 | 3,058 | 2,490 |
Net Property & Equipment | 1,816 | 1,766 | 1,707 | 1,627 | 1,453 |
Investments & Advances | 135 | 132 | 141 | 521 | 482 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 8,899 | 8,312 | 8,262 | 8,040 | 7,740 |
Deposits & Other Assets | 198 | 144 | 163 | 176 | 160 |
Total Assets | 14,022 | 12,837 | 13,611 | 14,026 | 12,843 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 1,359 | 1,396 | 1,600 | 1,633 | 1,041 |
Current Portion Long-Term Debt | 303 | 2 | 2 | 2 | 804 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 0 | 0 | 0 | 0 | 0 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Total Current Liabilities | 1,815 | 1,551 | 1,753 | 1,776 | 1,990 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 4,410 | 3,978 | 4,010 | 4,013 | 3,966 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 876 | 812 | 792 | 847 | 711 |
Minority Interest (Liabilities) | 76 | 77 | 79 | 82 | 76 |
Total Liabilities | 7,680 | 6,907 | 7,128 | 7,217 | 7,156 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 2 | 2 | 2 | 2 | 2 |
Capital Surplus | 2,320 | 2,295 | 2,260 | 2,841 | 2,722 |
Retained Earnings | 8,825 | 8,290 | 7,649 | 9,303 | 8,174 |
Other Equity | 21 | 16 | 25 | 29 | 7 |
Treasury Stock | 4,826 | 4,673 | 3,453 | 5,366 | 5,218 |
Total Shareholder's Equity | 6,342 | 5,930 | 6,483 | 6,809 | 5,687 |
Total Liabilities & Shareholder's Equity | 14,022 | 12,837 | 13,611 | 14,026 | 12,843 |
Total Common Equity | 6,342 | 5,930 | 6,483 | 6,809 | 5,687 |
Shares Outstanding | 112.40 | 113.80 | 122.60 | 134.70 | 134.70 |
Book Value Per Share | 56.42 | 52.11 | 52.88 | 50.55 | 42.22 |
Fiscal Year End for Quest Diagnostics Incorporated falls in the month of December.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 271 | 474 | 686 | 143 | 126 |
Receivables | 1,319 | 1,322 | 1,210 | 1,281 | 1,235 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 182 | 181 | 190 | 184 | 184 |
Other Current Assets | 245 | 251 | 286 | 207 | 188 |
Total Current Assets | 2,017 | 2,228 | 2,372 | 1,815 | 1,733 |
Net Property & Equipment | 1,832 | 1,810 | 1,816 | 1,830 | 1,814 |
Investments & Advances | 126 | 133 | 135 | 130 | 135 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 9,087 | 9,022 | 8,899 | 8,951 | 8,980 |
Deposits & Other Assets | 216 | 182 | 198 | 149 | 152 |
Total Assets | 13,881 | 13,954 | 14,022 | 13,482 | 13,425 |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 1,247 | 1,239 | 1,359 | 1,157 | 1,201 |
Current Portion Long-Term Debt | 606 | 906 | 303 | 304 | 518 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 0 | 0 | 0 | 0 | 0 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Total Current Liabilities | 2,012 | 2,298 | 1,815 | 1,618 | 1,875 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 3,816 | 3,804 | 4,410 | 3,946 | 3,777 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 811 | 876 | 874 | 901 | |
Minority Interest (Liabilities) | 79 | 77 | 76 | 76 | 77 |
Total Liabilities | 7,225 | 7,485 | 7,680 | 7,019 | 7,138 |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 2 | 2 | 2 | 2 | 2 |
Capital Surplus | 2,314 | 2,292 | 2,320 | 2,302 | 2,284 |
Retained Earnings | 9,080 | 8,935 | 8,825 | 8,711 | 8,566 |
Other Equity | 20 | 21 | 21 | 18 | 22 |
Treasury Stock | 4,760 | 4,781 | 4,826 | 4,570 | 4,587 |
Total Shareholder's Equity | 6,656 | 6,469 | 6,342 | 6,463 | 6,287 |
Total Liabilities & Shareholder's Equity | 13,881 | 13,954 | 14,022 | 13,482 | 13,425 |
Total Common Equity | 6,656 | 6,469 | 6,342 | 6,463 | 6,287 |
Shares Outstanding | 111.30 | 111.00 | 112.40 | 112.40 | 112.20 |
Book Value Per Share | 59.80 | 58.28 | 56.42 | 57.50 | 56.03 |